NDC 63323-328-41 - Nafcillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-328
- Requested NDC
- 63323-328-41
- Package NDCs from labels
- 63323-328-21, 63323-328-20, 63323-328-41, 63323-328-22
- Manufacturer
- Fresenius Kabi USA, LLC | Istituto Biochimico Italiano Giovanni Lorenzini
- Effective date
- 2026-10-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nafcillin for Injection, USP | Fresenius Kabi USA, LLC | Istituto Biochimico Italiano Giovanni Lorenzini | 2026-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Nafcillin for Injection, USP | Fresenius Kabi USA, LLC | Istituto Biochimico Italiano Giovanni Lorenzini | 2026-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-328-20 | Nafcillin | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 5 | |
| 63323-328-21 | Nafcillin | 8 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 8 | 5 | |
| 63323-328-22 | Nafcillin | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 4 | |
| 63323-328-22 | Nafcillin | 8 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 8 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-328 | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20190518_c39721a3-7b22-4720-9dbd-bc82f03d2af7.zip |
| 63323-328 | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20190525_3c2581a1-8051-4d7a-a1f7-521248648dc9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-328-20 | EA - Each | 63323-328 | 80c29cfa-ca39-4b40-a3ca-81b57c54283a | 1 | 2012-07-24 |
| 63323-328-21 | EA - Each | 63323-328 | ef28c6b0-e163-4fc7-85b4-1fde5e1fc9f9 | 1 | 2025-11-13 |
| 63323-328-22 | EA - Each | 63323-328 | a1e04f6d-efac-4fa8-a833-d6cdaede59a8 | 1 | 2018-08-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 | |
| NAFCILLIN | ACTIVE MOIETY | 4CNZ27M7RV | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Addiclenz | BOLDO, CARDUUS MARIANUS, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYL PARABEN, PROPYL PARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Deseret Biologicals, Inc. | 8a3b75ca-8fec-4318-8a55-8bde0b82637d | 2024-10-31 | Warnings | 1Q73Q2JULR |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | American Health Packaging | 58fa9952-c8ab-4ebb-a073-15cc45f4832a | 2024-07-16 | Adverse reactions | 1Q73Q2JULR |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell RX, LLC | 525136c9-7758-437b-b57b-94b905786825 | 2024-05-31 | Adverse reactions | 1Q73Q2JULR |
| Balanced Salt | SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, AND SODIUM CITRATE | B. Braun Medical Inc. | 74ab8883-0a5f-46b4-8998-9358f6fd4ef4 | 2024-03-13 | Warnings, Adverse reactions | 1Q73Q2JULR |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 1Q73Q2JULR |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 1Q73Q2JULR |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | 1Q73Q2JULR | |
| Nafcillin | NAFCILLIN | Fresenius Kabi USA, LLC | bbf0d8e4-b8e4-4958-b6b6-f0b9960f3b6a | 2019-06-12 | Warnings, Adverse reactions | 49G3001BCK |
| Additox | TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | BioActive Nutritional, Inc. | 319ee2fe-58e3-495e-bf0d-df201f6fbb1c | 2018-07-18 | Warnings | 1Q73Q2JULR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.